Skip to main content

IMC-Chicago, LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1452861 CHICAGO, IL

Position in TEVA

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$1,237,128
-$1,460,690 QoQ
Shares Held
36,515
-59.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#314
of 671 holders
Holding Since
Mar 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Derivatives in TEVA

reported options exposure · as of Sep 30, 2021
CallValue
$4,450,206
CallShares
456,900
PutValue
$3,555,100
PutShares
365,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

IMC-Chicago, LLC holds $58,181,394 across 12 Drug Manufacturers - Specialty & Generic names. TEVA ranks #5 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 TEVA
Teva Pharmaceutical Industries Ltd
This page
36,515 $1,237,128

All Filings in TEVA

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,237,128 36,515
2026-03-31 $2,697,818 89,569
2025-06-30 $1,544,031 92,126
2025-03-31 $1,105,963 71,956
2024-09-30 $600,570 33,328
2024-06-30 $1,142,456 70,305
2024-03-31 $354,838 25,148
2023-09-30 $930,790 91,254
2023-06-30 $1,000,962 132,930
2023-03-31 $2,034,163 229,849
2022-12-31 $950,988 104,275
2022-09-30 $617,459 76,513
2022-06-30 $1,406,224 186,998
2022-03-31 $1,227,770 130,753
2021-12-31 $1,929,504 240,887
2021-09-30 $3,555,100 365,000
2021-09-30 $4,450,206 456,900
2021-09-30 $1,073,825 110,249
2021-06-30 $1,303,602 131,677
2021-03-31 $951,034 82,412